Session Chair Profile

Ph.D., CEO, Immunai

Biography
Noam is the CEO and Co-Founder at immunai, the first and only company to map the entire immune system for better detection, diagnosis, and treatment of disease. Leveraging single-cell technologies and machine learning algorithms, immunai has mapped out thousands of immune cells and their functions, building the largest proprietary data set in the world for clinical immunological data. Prior to co-founding immunai, Noam had a dual career in both the industry and academia. Noam is a double PhD, and served as a post-doctoral researcher in the Mathematics department at MIT, and in the center of mathematical sciences and applications at Harvard University. In his research, he developed and applied tools from algebra and Algebraic Geometry in the study of classical problems in combinatorics. Noam also worked as an algorithms developer in the Israeli defense forces and subsequently as a data scientist, consultant and head of data science in several hi-tech companies in Israel.


 Session Abstract – PMWC 2022 Silicon Valley

Track 2 , June 29


The future of drug development is likely to be deeply impacted by machine learning in a multitude of ways. This panel will reflect on the past, present, and future of what has made drug discovery flourish and fail; with a special focus on the technology driving cutting-edge precision medicine.

 Session Abstract – PMWC 2022 Silicon Valley

Track 2 , June 29


  • Hope or Hype? The Role of ML in Drug Discovery and Development (PANEL)
    Session Chair: Ansuman Satpathy, Stanford University
    - Marcel Hop, Genentech
    - Noam Solomon, ImmunAI
    - Stacie Calad-Thomson, BioSymetrics
    - Andrea deSouza, Eli Lilly and Company
  • Advancing Research and Drug Discovery with UK Biobank
    Session Chair: Asha Collins, DNAnexus
    - Mahesh Pancholi, UK Biobank
  • Machine Learning for Novel Target Discovery: Unique Techniques Meet Unique Data
    Session Chair: Alex Morgan, Khosla Ventures
    - Lindsay Edwards, Relation Therapeutics
    - Kristen Fortney, BioAge
    - Quin Wills, Ochre Bio
    - Joseph Rodgers, Fountain Therapeutics
    - Calum MacRae, Atman Health
  • AI in Small Molecule Design and Screening (PANEL)
    Session Chair: Alex Zhavoronkov, Insilico Medicine
    - Jim Edwards, Janssen
    - Tommaso Mansi, Johnson & Johnson
    - Martin Emanuel Bittner, Arctoris
  • AI/ML in Clinical Trial Design, Patient Selection and Prediction of Outcomes (PANEL)
    Session Chair: Peter Lipsky, Ampel Bio
    - Nasim Eftekhari, City of Hope
    - Mika Newton, xCures, Inc.
    - Mark Smith, MedStar Health
    - William Oh, Sema4
  • Treating Genetics as Data: Computable, Structured Results for Precision Medicine
    - Peter DeVault, Epic
  • PMWC 2022 Showcase
    - Kevin Cho, Envisagenics, Inc.
    - Poojitha Ojamies, Novartis
    - Steve Harrison, Engine Biosciences